Omni Bio Pharmaceutical, Inc. filed its 10-K on Jun 28, 2013 for the period ending Mar 31, 2013. In this report its auditor, Hein & Associates LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.